Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR

Published:2018-03 Issue:2 Volume:17 Page:228-235
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Taylor-Cousar Jennifer L.,Jain Manu,Barto Tara Lynn,Haddad Tarik,Atkinson Jeffrey,Tian Simon,Tang Rui,Marigowda Gautham,Waltz David,Pilewski Joseph

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference21 articles.

1. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR;Wainwright;N Engl J Med,2015

2. Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study;Konstan;Lancet Respir Med,2017

3. Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis;Goss;Thorax,2007

4. Prediction of mortality in patients with cystic fibrosis;Kerem;N Engl J Med,1992

5. Heterogeneity in survival in adult patients with cystic fibrosis with FEV1 <30% of predicted in the United States;Ramos;Chest,2017

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human epididymis protein 4 (HE4) plasma concentration inversely correlates with the improvement of cystic fibrosis lung disease in p.Phe508del-CFTR homozygous cases treated with the CFTR modulator lumacaftor/ivacaftor combination;Journal of Cystic Fibrosis;2023-11

2. Long-term clinical outcomes of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis and advanced pulmonary disease;Respiratory Medicine;2023-11

3. Use of CFTR modulators in special populations, part 2: Severe lung disease;Pediatric Pulmonology;2023-09-20

4. Real‐life experience with a generic formulation of lumacaftor‐ivacaftor in patients with cystic fibrosis homozygous for the Phe508del CFTR mutation;Pediatric Pulmonology;2023-09-15

5. Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association);Jornal Brasileiro de Pneumologia;2023-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3